View |
|
DRP-13371
|
Tranexamic Acid
|
Tranexsaph
|
500 mg
|
Capsule
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial
|
08 February 2023
|
08 February 2028
|
View |
|
DR-XY48609
|
Rivaroxaban
|
Xarelto
|
10 mg
|
Film-Coated Tablet
|
-
|
Bayer Bitterfeld GmbH
|
Germany
|
Initial
|
08 February 2023
|
08 February 2028
|
View |
|
DR-XY30512
|
Simvastatin
|
Vidastat
|
80 mg
|
Film-Coated Tablet
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
09 February 2023
|
31 May 2027
|
View |
|
DRP-9764
|
Silver Sulfadiazine
|
Silbecor (Alu Tube)
|
10mg/g (1% w/w)
|
Cream
|
-
|
Unique Pharmaceuticals Laboratories (A Division of
J.B. Chemicals & Pharmaceuticals Ltd.)
|
India
|
Initial
|
02 June 2021
|
02 June 2026
|
View |
|
DR-XY38958
|
Cefdinir
|
Omnicef [for Export Only]
|
125mg/ 5mL
|
Powder for Oral Suspension
|
-
|
Interphil Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
29 October 2022
|
18 January 2026
|
View |
|
DRP-12696
|
Celecoxib
|
None
|
100mg
|
Capsule
|
-
|
Centurion Laboratories Pvt. Ltd.
|
India
|
Initial
|
23 September 2022
|
23 September 2027
|
View |
|
DRP-4854-10
|
Esomeprazole (As Sodium)
|
Esomepracor
|
40 mg
|
Lyophilized Powder For Injection (I.V.)
|
Proton Pump Inhibitor
|
Brawn Laboratories Limited
|
India
|
Automatic Renewal
|
13 March 2023
|
23 October 2028
|
View |
|
DRP-13475
|
Ipratropium bromide + Salbutamol (as sulfate)
|
Sapium
|
500 mcg/2.5 mg
|
Solution for Inhalation
|
-
|
Legency Remedies Pvt. Ltd.
|
India
|
Initial
|
27 February 2023
|
27 February 2028
|
View |
|
DRP-13409
|
Febuxostat
|
Urixokind-40
|
40mg
|
Film-Coated Tablet
|
-
|
Mankind Pharma Limited (Unit II)
|
India
|
Initial
|
02 March 2023
|
02 March 2028
|
View |
|
DR-XY48637
|
Rocuronium Bromide
|
Kabiroc
|
10 mg/mL
|
Solution For Injection (IV)
|
-
|
PT. Ethica Industri Farmasi
|
Indonesia
|
Initial
|
23 February 2023
|
23 February 2028
|
View |
|
DRP-13509
|
Etoricoxib
|
None
|
60 mg
|
Film-Coated Tablet
|
-
|
KRKA, d.d., Novo Mesto
|
Slovenia
|
Initial
|
02 March 2023
|
02 March 2028
|
View |
|
DRP-13508
|
Etoricoxib
|
None
|
120 mg
|
Film-Coated Tablet
|
-
|
KRKA, d.d., Novo Mesto
|
Slovenia
|
Initial
|
02 March 2023
|
02 March 2028
|
View |
|
DRP-13510
|
Etoricoxib
|
None
|
90 mg
|
Film-Coated Tablet
|
-
|
KRKA, d.d., Novo Mesto
|
Slovenia
|
Initial
|
02 March 2023
|
02 March 2028
|
View |
|
DRP-13466
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Zeutreme
|
2 g/250 mg
|
Powder for Solution for IV Infusion
|
-
|
Reyoung Pharmaceutical Co. Ltd.
|
China
|
Initial
|
23 February 2023
|
23 February 2028
|
View |
|
DRP-13464
|
Acetylcysteine
|
Musilac
|
600 mg
|
Effervescent Tablet (Orange Flavor)
|
-
|
Globela Pharma Private Limited
|
India
|
Initial
|
23 February 2023
|
23 February 2028
|
View |
|
DRP-13489
|
Clopidogrel (as bisulfate)
|
Copide
|
75mg
|
Film-Coated Tablet
|
-
|
Globela Pharma Private Limited
|
India
|
Initial
|
27 February 2023
|
27 February 2028
|
View |
|
DRP-13487
|
Tramadol Hydrochloride
|
Ambidol
|
50mg
|
Capsule
|
-
|
Fredun Pharmaceuticals Limited
|
India
|
Initial
|
27 February 2023
|
27 February 2028
|
View |
|
DRP-13460
|
Latanoprost
|
Lprost
|
50 mcg/mL (0.005% w/v)
|
Ophthalmic Solution
(Eye drops)
|
-
|
Joint Stock Company "Farmak"
|
Ukraine
|
Initial
|
23 February 2023
|
23 February 2028
|
View |
|
DRP-13463
|
Paracetamol
|
Parasaph-Inf
|
10 mg/mL (1 g/100 mL)
|
Solution for IV Infusion
|
-
|
Althea Pharma Pvt. Ltd.
|
India
|
Initial
|
23 February 2023
|
23 February 2028
|
View |
|
DRP-13462
|
Acetylcysteine
|
Mucoright
|
600 mg
|
Effervescent Tablet (ORange Flavor)
|
-
|
Vovantis Laboratories Private Limited
|
India
|
Initial
|
23 February 2023
|
23 February 2026
|